Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03883022

Vancomycin Powder Combined With Autogenous Bone Graft as a Prevention for Post-operative Infection for Spine Surgery

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Taipei Veterans General Hospital, Taiwan · Other Government
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Deep surgical site infection (DSSI) is one of the most challenging complications for spinal surgeons and can lead to a poor clinical outcome. This ambispective study was designed to examine the effect of vancomycin powder mixed with autogenous bone graft and bone substitute on preventing deep surgical site infection (DSSI) in degenerative lumbar fusion surgeries as well as any interference with bony fusion.

Conditions

Interventions

TypeNameDescription
DRUGwith U-VANCO (vancomycin hydrochloride)1 gm or 2 gm mixed with autogenous cancellous bone graft
DRUGwithout U-VANCO (vancomycin hydrochloride)no vancomycin added

Timeline

Start date
2018-09-03
Primary completion
2027-09-12
Completion
2027-12-31
First posted
2019-03-20
Last updated
2019-03-20

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03883022. Inclusion in this directory is not an endorsement.